A solid-phase immunoradiometric assay for serum ferritin has been developed and applied to 30 patients with chronic myeloid leukemia (CML), including 13 patients with a typical chronic phase, 12 with bone marrow fibrosis without evidence of an acute phase and 5 with an acute phase. Patients were divided in to three subgroups according to the erythrokinetic data as studied by the 59iron kinetic test. Serum ferritin was clearly correlated with the quality of erythropoiesis but not with blast cell mass nor white cell count. Given the prognostic value of dyserythropoiesis in the course of CML, serum ferritin determination may be a helpful and simple parameter in the follow-up of CML patients.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.